November 23, 2021 — A novel device called venous external support (VEST) may lead to increased longevity and durability ...
November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents ...
November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 22, 2021 — Atlantic Health System’s Morristown Medical Center announced that it has enrolled the first patient ...
November 22, 2021 — Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results ...
November 22, 2021 — Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 22, 2021 — The Minneapolis Heart Institute Foundation (MHIF) announced the publication of research showing ...
Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...
Susan Cheng, M.D., MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Susan Cheng, M.D., MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at ...
November 19, 2021 — Adults treated with empagliflozin during hospitalization for acute heart failure experienced a ...
November 19, 2021 — Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated ...
November 19, 2021 — Results from two early clinical studies show the first version of an oral PCSK9-inhibitor ...
November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...